InChI=1S/C34H56N2O27/c1- 9(41) 35- 17- 11(43) 3- 33(31(53) 54,61- 26(17) 19(46) 13(45) 5- 37) 60- 15(7- 39) 21(48) 27- 18(36- 10(2) 42) 12(44) 4- 34(62- 27,32(55) 56) 63- 28- 20(47) 14(6- 38) 58- 30(24(28) 51) 59- 25- 16(8- 40) 57- 29(52) 23(50) 22(25) 49/h11- 30,37- 40,43- 52H,3- 8H2,1- 2H3,(H,35,41) (H,36,42) (H,53,54) (H,55,56) /t11- ,12- ,13+,14+,15+,16+,17+,18+,19+,20- ,21+,22+,23+,24+,25+,26+,27+,28- ,29+,30- ,33+,34- /m0/s1 |
IESOVNOGVZBLMG-BUZVEHKISA-N |
[H] [C@] 1(O[C@@] (C[C@H] (O) [C@H] 1NC(C) =O) (O[C@H] (CO) [C@@H] (O) [C@] 1([H] ) O[C@@] (C[C@H] (O) [C@H] 1NC(C) =O) (O[C@H] 1[C@@H] (O) [C@@H] (CO) O[C@@H] (O[C@H] 2[C@H] (O) [C@@H] (O) [C@H] (O) O[C@@H] 2CO) [C@@H] 1O) C(O) =O) C(O) =O) [C@H] (O) [C@H] (O) CO |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
View more via ChEBI Ontology
Outgoing
|
α- Neup5Ac- (2→8)- α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- β- D- Glcp
(CHEBI:59210)
is a
acetamides
(CHEBI:22160)
α- Neup5Ac- (2→8)- α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- β- D- Glcp
(CHEBI:59210)
is a
amino tetrasaccharide
(CHEBI:59412)
α- Neup5Ac- (2→8)- α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- β- D- Glcp
(CHEBI:59210)
is a
dicarboxylic acid
(CHEBI:35692)
|
|
Incoming
|
α-Neup5Ac-(2→8)-α-Neup5Ac-(2→3)-β-D-Galp-(1→4)-β-D-Glcp-yl group
(CHEBI:142532)
is substituent group from
α- Neup5Ac- (2→8)- α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- β- D- Glcp
(CHEBI:59210)
|
5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→8)- 5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→3)- β- D- galactopyranosyl- (1→4)- β- D- glucopyranose
|
Neu5Aca2-8Neu5Aca2-3Galb1-4Glcb
|
Neu5Acα2-8Neu5Acα2-3Galβ1-4Glcβ
|
α- N- acetylneuraminyl- (2→8)- α- N- acetylneuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucose
|
ChEBI
|
α- Neu5Ac- (2→8)- α- Neu5Ac- (2→3)- β- D- Gal- (1→4)- β- D- Glc
|
ChEBI
|
β- D- glucopyranose, O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→8)- O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→3)- O- β- D- galactopyranosyl- (1→4)-
|
ChEBI
|
disialyllactose
|
ChEBI
|
GD3 carbohydrate moiety
|
ChEBI
|
N- acetyl- α- neuraminyl- (2→8)- N- acetyl- α- neuraminyl- (2→3)- β- D- galactosyl- (1→4)- β- D- glucose
|
ChEBI
|
O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→8)- O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→3)- O- β- D- galactopyranosyl- (1→4)- β- D- glucopyranose
|
ChEBI
|
WURCS=2.0/3,4,3/[a2122h-1b_1-5][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O]/1-2-3-3/a4-b1_b3-c2_c8-d2
|
GlyTouCan
|
5236295
|
Reaxys Registry Number
|
Reaxys
|
5326295
|
Beilstein Registry Number
|
Beilstein
|
12183547
|
PubMed citation
|
Europe PMC
|
14960498
|
PubMed citation
|
Europe PMC
|
19443021
|
PubMed citation
|
Europe PMC
|
21683945
|
PubMed citation
|
Europe PMC
|
25568069
|
PubMed citation
|
Europe PMC
|
31537530
|
PubMed citation
|
Europe PMC
|
33164488
|
PubMed citation
|
Europe PMC
|
|